This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy Product. This report contains market size and forecasts of Cellular and Gene Therapy Product in global, including the following market information:
Global Cellular and Gene Therapy Product Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cellular and Gene Therapy Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cellular Immunotherapies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cellular and Gene Therapy Product include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center and LifeSouth Community Blood Centers, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cellular and Gene Therapy Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cellular and Gene Therapy Product Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cellular and Gene Therapy Product Market Segment Percentages, by Type, 2022 (%)
Cellular Immunotherapies
Cancer Vaccines
Autologous and Allogeneic Cells
Global Cellular and Gene Therapy Product Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cellular and Gene Therapy Product Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Prostate Cancer
Skin Cancer
Other
Global Cellular and Gene Therapy Product Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cellular and Gene Therapy Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular and Gene Therapy Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cellular and Gene Therapy Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
New York Blood Center
Johnson & Johnson
Cleveland Cord Blood Center
Organogenesis
Duke University School of Medicine
Colorado Cord Blood Banking
MD Anderson Cancer Center
LifeSouth Community Blood Centers
Bloodworks Northwest
Amgen
Novartis Pharmaceuticals
Castle Creek Biosciences
Spark Therapeutics
Vericel
Dendreon Pharmaceuticals
Enzyvant Therapeutics GmbH
Mallinckrodt
Gilead Sciences
bluebird bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cellular and Gene Therapy Product, market overview.
Chapter 2: Global Cellular and Gene Therapy Product market size in revenue.
Chapter 3: Detailed analysis of Cellular and Gene Therapy Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cellular and Gene Therapy Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cellular and Gene Therapy Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular and Gene Therapy Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular and Gene Therapy Product Overall Market Size
2.1 Global Cellular and Gene Therapy Product Market Size: 2022 VS 2029
2.2 Global Cellular and Gene Therapy Product Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cellular and Gene Therapy Product Players in Global Market
3.2 Top Global Cellular and Gene Therapy Product Companies Ranked by Revenue
3.3 Global Cellular and Gene Therapy Product Revenue by Companies
3.4 Top 3 and Top 5 Cellular and Gene Therapy Product Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cellular and Gene Therapy Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cellular and Gene Therapy Product Players in Global Market
3.6.1 List of Global Tier 1 Cellular and Gene Therapy Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Cellular and Gene Therapy Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cellular and Gene Therapy Product Market Size Markets, 2022 & 2029
4.1.2 Cellular Immunotherapies
4.1.3 Cancer Vaccines
4.1.4 Autologous and Allogeneic Cells
4.2 By Type - Global Cellular and Gene Therapy Product Revenue & Forecasts
4.2.1 By Type - Global Cellular and Gene Therapy Product Revenue, 2018-2023
4.2.2 By Type - Global Cellular and Gene Therapy Product Revenue, 2024-2029
4.2.3 By Type - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular and Gene Therapy Product Market Size, 2022 & 2029
5.1.2 Blood Cancer
5.1.3 Prostate Cancer
5.1.4 Skin Cancer
5.1.5 Other
5.2 By Application - Global Cellular and Gene Therapy Product Revenue & Forecasts
5.2.1 By Application - Global Cellular and Gene Therapy Product Revenue, 2018-2023
5.2.2 By Application - Global Cellular and Gene Therapy Product Revenue, 2024-2029
5.2.3 By Application - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cellular and Gene Therapy Product Market Size, 2022 & 2029
6.2 By Region - Global Cellular and Gene Therapy Product Revenue & Forecasts
6.2.1 By Region - Global Cellular and Gene Therapy Product Revenue, 2018-2023
6.2.2 By Region - Global Cellular and Gene Therapy Product Revenue, 2024-2029
6.2.3 By Region - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cellular and Gene Therapy Product Revenue, 2018-2029
6.3.2 US Cellular and Gene Therapy Product Market Size, 2018-2029
6.3.3 Canada Cellular and Gene Therapy Product Market Size, 2018-2029
6.3.4 Mexico Cellular and Gene Therapy Product Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cellular and Gene Therapy Product Revenue, 2018-2029
6.4.2 Germany Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.3 France Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.4 U.K. Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.5 Italy Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.6 Russia Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.7 Nordic Countries Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.8 Benelux Cellular and Gene Therapy Product Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cellular and Gene Therapy Product Revenue, 2018-2029
6.5.2 China Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.3 Japan Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.4 South Korea Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.5 Southeast Asia Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.6 India Cellular and Gene Therapy Product Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cellular and Gene Therapy Product Revenue, 2018-2029
6.6.2 Brazil Cellular and Gene Therapy Product Market Size, 2018-2029
6.6.3 Argentina Cellular and Gene Therapy Product Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cellular and Gene Therapy Product Revenue, 2018-2029
6.7.2 Turkey Cellular and Gene Therapy Product Market Size, 2018-2029
6.7.3 Israel Cellular and Gene Therapy Product Market Size, 2018-2029
6.7.4 Saudi Arabia Cellular and Gene Therapy Product Market Size, 2018-2029
6.7.5 UAE Cellular and Gene Therapy Product Market Size, 2018-2029
7 Cellular and Gene Therapy Product Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Major Product Offerings
7.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 New York Blood Center
7.2.1 New York Blood Center Company Summary
7.2.2 New York Blood Center Business Overview
7.2.3 New York Blood Center Cellular and Gene Therapy Product Major Product Offerings
7.2.4 New York Blood Center Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.2.5 New York Blood Center Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Cellular and Gene Therapy Product Major Product Offerings
7.3.4 Johnson & Johnson Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Cleveland Cord Blood Center
7.4.1 Cleveland Cord Blood Center Company Summary
7.4.2 Cleveland Cord Blood Center Business Overview
7.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Major Product Offerings
7.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.4.5 Cleveland Cord Blood Center Key News & Latest Developments
7.5 Organogenesis
7.5.1 Organogenesis Company Summary
7.5.2 Organogenesis Business Overview
7.5.3 Organogenesis Cellular and Gene Therapy Product Major Product Offerings
7.5.4 Organogenesis Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.5.5 Organogenesis Key News & Latest Developments
7.6 Duke University School of Medicine
7.6.1 Duke University School of Medicine Company Summary
7.6.2 Duke University School of Medicine Business Overview
7.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Major Product Offerings
7.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.6.5 Duke University School of Medicine Key News & Latest Developments
7.7 Colorado Cord Blood Banking
7.7.1 Colorado Cord Blood Banking Company Summary
7.7.2 Colorado Cord Blood Banking Business Overview
7.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Major Product Offerings
7.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.7.5 Colorado Cord Blood Banking Key News & Latest Developments
7.8 MD Anderson Cancer Center
7.8.1 MD Anderson Cancer Center Company Summary
7.8.2 MD Anderson Cancer Center Business Overview
7.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Major Product Offerings
7.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.8.5 MD Anderson Cancer Center Key News & Latest Developments
7.9 LifeSouth Community Blood Centers
7.9.1 LifeSouth Community Blood Centers Company Summary
7.9.2 LifeSouth Community Blood Centers Business Overview
7.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Major Product Offerings
7.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.9.5 LifeSouth Community Blood Centers Key News & Latest Developments
7.10 Bloodworks Northwest
7.10.1 Bloodworks Northwest Company Summary
7.10.2 Bloodworks Northwest Business Overview
7.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Major Product Offerings
7.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.10.5 Bloodworks Northwest Key News & Latest Developments
7.11 Amgen
7.11.1 Amgen Company Summary
7.11.2 Amgen Business Overview
7.11.3 Amgen Cellular and Gene Therapy Product Major Product Offerings
7.11.4 Amgen Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.11.5 Amgen Key News & Latest Developments
7.12 Novartis Pharmaceuticals
7.12.1 Novartis Pharmaceuticals Company Summary
7.12.2 Novartis Pharmaceuticals Business Overview
7.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Major Product Offerings
7.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.12.5 Novartis Pharmaceuticals Key News & Latest Developments
7.13 Castle Creek Biosciences
7.13.1 Castle Creek Biosciences Company Summary
7.13.2 Castle Creek Biosciences Business Overview
7.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Major Product Offerings
7.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.13.5 Castle Creek Biosciences Key News & Latest Developments
7.14 Spark Therapeutics
7.14.1 Spark Therapeutics Company Summary
7.14.2 Spark Therapeutics Business Overview
7.14.3 Spark Therapeutics Cellular and Gene Therapy Product Major Product Offerings
7.14.4 Spark Therapeutics Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.14.5 Spark Therapeutics Key News & Latest Developments
7.15 Vericel
7.15.1 Vericel Company Summary
7.15.2 Vericel Business Overview
7.15.3 Vericel Cellular and Gene Therapy Product Major Product Offerings
7.15.4 Vericel Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.15.5 Vericel Key News & Latest Developments
7.16 Dendreon Pharmaceuticals
7.16.1 Dendreon Pharmaceuticals Company Summary
7.16.2 Dendreon Pharmaceuticals Business Overview
7.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Major Product Offerings
7.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.16.5 Dendreon Pharmaceuticals Key News & Latest Developments
7.17 Enzyvant Therapeutics GmbH
7.17.1 Enzyvant Therapeutics GmbH Company Summary
7.17.2 Enzyvant Therapeutics GmbH Business Overview
7.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Major Product Offerings
7.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.17.5 Enzyvant Therapeutics GmbH Key News & Latest Developments
7.18 Mallinckrodt
7.18.1 Mallinckrodt Company Summary
7.18.2 Mallinckrodt Business Overview
7.18.3 Mallinckrodt Cellular and Gene Therapy Product Major Product Offerings
7.18.4 Mallinckrodt Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.18.5 Mallinckrodt Key News & Latest Developments
7.19 Gilead Sciences
7.19.1 Gilead Sciences Company Summary
7.19.2 Gilead Sciences Business Overview
7.19.3 Gilead Sciences Cellular and Gene Therapy Product Major Product Offerings
7.19.4 Gilead Sciences Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.19.5 Gilead Sciences Key News & Latest Developments
7.20 bluebird bio
7.20.1 bluebird bio Company Summary
7.20.2 bluebird bio Business Overview
7.20.3 bluebird bio Cellular and Gene Therapy Product Major Product Offerings
7.20.4 bluebird bio Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.20.5 bluebird bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cellular and Gene Therapy Product Market Opportunities & Trends in Global Market
Table 2. Cellular and Gene Therapy Product Market Drivers in Global Market
Table 3. Cellular and Gene Therapy Product Market Restraints in Global Market
Table 4. Key Players of Cellular and Gene Therapy Product in Global Market
Table 5. Top Cellular and Gene Therapy Product Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cellular and Gene Therapy Product Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cellular and Gene Therapy Product Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cellular and Gene Therapy Product Product Type
Table 9. List of Global Tier 1 Cellular and Gene Therapy Product Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cellular and Gene Therapy Product Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cellular and Gene Therapy Product Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cellular and Gene Therapy Product Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cellular and Gene Therapy Product Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cellular and Gene Therapy Product Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cellular and Gene Therapy Product Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cellular and Gene Therapy Product Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cellular and Gene Therapy Product Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cellular and Gene Therapy Product Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cellular and Gene Therapy Product Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cellular and Gene Therapy Product Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cellular and Gene Therapy Product Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cellular and Gene Therapy Product Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cellular and Gene Therapy Product Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cellular and Gene Therapy Product Revenue, (US$, Mn), 2024-2029
Table 30. Bristol-Myers Squibb Company Summary
Table 31. Bristol-Myers Squibb Cellular and Gene Therapy Product Product Offerings
Table 32. Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Key News & Latest Developments
Table 34. New York Blood Center Company Summary
Table 35. New York Blood Center Cellular and Gene Therapy Product Product Offerings
Table 36. New York Blood Center Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 37. New York Blood Center Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Cellular and Gene Therapy Product Product Offerings
Table 40. Johnson & Johnson Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. Cleveland Cord Blood Center Company Summary
Table 43. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Offerings
Table 44. Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 45. Cleveland Cord Blood Center Key News & Latest Developments
Table 46. Organogenesis Company Summary
Table 47. Organogenesis Cellular and Gene Therapy Product Product Offerings
Table 48. Organogenesis Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 49. Organogenesis Key News & Latest Developments
Table 50. Duke University School of Medicine Company Summary
Table 51. Duke University School of Medicine Cellular and Gene Therapy Product Product Offerings
Table 52. Duke University School of Medicine Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 53. Duke University School of Medicine Key News & Latest Developments
Table 54. Colorado Cord Blood Banking Company Summary
Table 55. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Offerings
Table 56. Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 57. Colorado Cord Blood Banking Key News & Latest Developments
Table 58. MD Anderson Cancer Center Company Summary
Table 59. MD Anderson Cancer Center Cellular and Gene Therapy Product Product Offerings
Table 60. MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 61. MD Anderson Cancer Center Key News & Latest Developments
Table 62. LifeSouth Community Blood Centers Company Summary
Table 63. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Offerings
Table 64. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 65. LifeSouth Community Blood Centers Key News & Latest Developments
Table 66. Bloodworks Northwest Company Summary
Table 67. Bloodworks Northwest Cellular and Gene Therapy Product Product Offerings
Table 68. Bloodworks Northwest Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 69. Bloodworks Northwest Key News & Latest Developments
Table 70. Amgen Company Summary
Table 71. Amgen Cellular and Gene Therapy Product Product Offerings
Table 72. Amgen Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 73. Amgen Key News & Latest Developments
Table 74. Novartis Pharmaceuticals Company Summary
Table 75. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Offerings
Table 76. Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 77. Novartis Pharmaceuticals Key News & Latest Developments
Table 78. Castle Creek Biosciences Company Summary
Table 79. Castle Creek Biosciences Cellular and Gene Therapy Product Product Offerings
Table 80. Castle Creek Biosciences Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 81. Castle Creek Biosciences Key News & Latest Developments
Table 82. Spark Therapeutics Company Summary
Table 83. Spark Therapeutics Cellular and Gene Therapy Product Product Offerings
Table 84. Spark Therapeutics Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 85. Spark Therapeutics Key News & Latest Developments
Table 86. Vericel Company Summary
Table 87. Vericel Cellular and Gene Therapy Product Product Offerings
Table 88. Vericel Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 89. Vericel Key News & Latest Developments
Table 90. Dendreon Pharmaceuticals Company Summary
Table 91. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Offerings
Table 92. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 93. Dendreon Pharmaceuticals Key News & Latest Developments
Table 94. Enzyvant Therapeutics GmbH Company Summary
Table 95. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Offerings
Table 96. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 97. Enzyvant Therapeutics GmbH Key News & Latest Developments
Table 98. Mallinckrodt Company Summary
Table 99. Mallinckrodt Cellular and Gene Therapy Product Product Offerings
Table 100. Mallinckrodt Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 101. Mallinckrodt Key News & Latest Developments
Table 102. Gilead Sciences Company Summary
Table 103. Gilead Sciences Cellular and Gene Therapy Product Product Offerings
Table 104. Gilead Sciences Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 105. Gilead Sciences Key News & Latest Developments
Table 106. bluebird bio Company Summary
Table 107. bluebird bio Cellular and Gene Therapy Product Product Offerings
Table 108. bluebird bio Cellular and Gene Therapy Product Revenue (US$, Mn) & (2018-2023)
Table 109. bluebird bio Key News & Latest Developments
List of Figures
Figure 1. Cellular and Gene Therapy Product Segment by Type in 2022
Figure 2. Cellular and Gene Therapy Product Segment by Application in 2022
Figure 3. Global Cellular and Gene Therapy Product Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cellular and Gene Therapy Product Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cellular and Gene Therapy Product Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cellular and Gene Therapy Product Revenue in 2022
Figure 8. By Type - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cellular and Gene Therapy Product Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cellular and Gene Therapy Product Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 16. US Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 20. Germany Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 21. France Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 28. China Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 32. India Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 34. Brazil Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
Figure 37. Turkey Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cellular and Gene Therapy Product Revenue, (US$, Mn), 2018-2029
Figure 41. Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. New York Blood Center Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Johnson & Johnson Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Organogenesis Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Duke University School of Medicine Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bloodworks Northwest Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Amgen Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Castle Creek Biosciences Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Spark Therapeutics Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Vericel Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Mallinckrodt Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Gilead Sciences Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. bluebird bio Cellular and Gene Therapy Product Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
